Quality of life of patients with irritable bowel syndrome is low compared to others with chronic diseases
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal dysmotility disorder. This study aimed to estimate the burden of illness of a Dutch population of community dwelling patients suffering from IBS. METHODS: Patients identified at community pharmacies, using mebeverine as a proxy for IBS, were administered a questionnaire regarding (1) the Rome II criteria for IBS, (2) predominant type of stool during complaints, (3) severity of symptoms (abdominal pain and discomfort), (4) generic and disease-specific quality of life, (5) current health status (utilities), and (6) loss of productivity. RESULTS: Three hundred and seventy-five users of mebeverine were identified of which 169 patients met the Rome II criteria for IBS, and were included in the study. More than half (58%) of the IBS patients reported severe abdominal pain and complaints. Generic and disease-specific quality of life outcomes showed impairment on all dimensions. Current health status in IBS patients, calculated on the basis of the EQ-5D VAS, was perceived on 62% of full health (95% CI, 60-66%). A calculation of health status in these patients based on the SF-6D algorithm showed a comparable score of 0.67 (1 is full health; 95% CI, 0.65-0.68). The loss in productivity of IBS patients was 1.8 days (95% CI, 1.1-2.5) per month. CONCLUSIONS: This study confirmed that the burden of illness of IBS in the Netherlands is substantial. IBS patients treated with mebeverine experienced low quality of life and suffered from severe pain. Based on these results, more attention for the diagnosis and treatment of IBS seems to be justified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although IBS is not a lifethreatening disease, health-related quality of life (HRQoL) is impaired.[10][11][12][13]”
Citations
Cites
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
The estimation of a preference-based measure of health from the SF-36
Brazier, J., Roberts, J., & Deverill, M. (2002) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00130-8 · Cited by 3,026
Aaronson, N. K., Muller, M., Cohen, P. D. A., Essink-Bot, M.-L., Fekkes, M., Sanderman, R., Sprangers, M. A. G., te Velde, A., & Verrips, E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00097-3 · Cited by 2,276
A comparison of the EQ‐5D and SF‐6D across seven patient groups
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004) · Health Economics · doi:10.1002/hec.866 · Cited by 797
Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Aaronson, N. K., Mosconi, P., Rasmussen, N. K., Bullinger, M., Fukuhara, S., Kaasa, S., et al. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018472.46236.05 · Cited by 786
Hungin, A. P. S., Whorwell, P. J., Tack, J., & Mearin, F. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01456.x · Cited by 781
The impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781
Deriving a Preference-Based Single Index from the UK SF-36 Health Survey
Brazier, J., Usherwood, T., Harper, R., & Thomas, K. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00103-6 · Cited by 686
Ware, J. E., Gandek, B., Kosinski, M., Aaronson, N. K., Apolone, G., Brazier, J., Bullinger, M., Kaasa, S., Leplège, A., Prieto, L., et al. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00108-5 · Cited by 560
Health state valuations from the general public using the Visual Analogue Scale
Gudex, C., Dolan, P., Kind, P., & Williams, A. (1996) · Quality of Life Research · doi:10.1007/bf00439226 · Cited by 244
Research works printed but not linked: 3
- Donker, 1999, Br J Gen Pract, 49, 787
- Janssen, 2000, Br J Gen Pract, 50, 375
- van der Horst, 2001, Geneesmiddelenbulletin, 36, 15
Cited by
GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C. ‐., & MATUCHANSKY, C. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03362.x · Cited by 365
Drouault-Holowacz, S., Bieuvelet, S., Burckel, A., Cazaubiel, M., Dray, X., & Marteau, P. (2008) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2007.06.001 · Cited by 151
Flik, C. E., Laan, W., Zuithoff, N. P. A., van Rood, Y. R., Smout, A. J. P. M., Weusten, B. L. A. M., Whorwell, P. J., & de Wit, N. J. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30310-8 · Cited by 126
Self-citation
Metadata
- Authors
- ten Berg, M. J., Goettsch, W. G., van den Boom, G., Smout, A. J. P. M., & Herings, R. M. C.
- Affiliations
- Pharmo Institute (NL)
- University Medical Center Utrecht (NL)
- Utrecht University (NL)
- Corresponding author
- Goettsch, Wim G.
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 2006-05
- Volume
- 18
- Issue
- 5
- Pages
- 475-481
- ISSN
- 0954-691X (ISSN-L)
- OpenAlex
- W1992494082
- Cited by
- 35
- References
- 24
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 2
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Keywords
- irritable bowel syndrome, quality of life, disease burden, mebeverine, abdominal pain, health status, productivity loss, Rome II criteria, community pharmacy patients, EQ-5D, SF-6D
- MeSH terms
- Chronic Disease, Constipation, Diarrhea, Female, Health Status, Health Surveys, Humans, Male, Middle Aged, Parasympatholytics, Phenethylamines, Quality of Life, Surveys and Questionnaires, Abdominal Pain, Cost of Illness, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quality of life of patients with irritable bowel syndrome is low compared to others with chronic diseases. https://app.cochat.ai/papers/10.1097/00042737-200605000-00004
- The paper
- ten Berg, M. J., Goettsch, W. G., van den Boom, G., Smout, A. J. P. M., & Herings, R. M. C. (2006). Quality of life of patients with irritable bowel syndrome is low compared to others with chronic diseases. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/00042737-200605000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.